Tongrentang's Subsidiary Secures Hong Kong Registration for Traditional Chinese Medicine Product

Stock News
05/26

Beijing Tong Ren Tang Co.,Ltd. (600085.SH) has announced that its controlled subsidiary, TONGRENTANGCM, has obtained a Certificate of Registration for Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong. This certificate authorizes the sale of "Antelope Horn Powder Capsules [Tongrentang]" in the Hong Kong Special Administrative Region of the People's Republic of China.

Following the receipt of this registration certificate, TONGRENTANGCM's Antelope Horn Powder Capsules [Tongrentang] are now permitted for sale in Hong Kong. This development is expected to help diversify the company's product portfolio and support its market expansion efforts. The acquisition of this registration is not anticipated to have a significant immediate impact on the company's production operations or financial performance.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10